AbbVie Inc. Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 150.56 B146.53 B138.81 B134.71 B135.16 B133.96 B Total du passif 159.4 B154.54 B146.43 B150.69 B157.57 B164.87 B Total des capitaux propres 13.1 B15.44 B17.29 B10.4 B3.36 B-3.23 B Total du passif et des capitaux propres 150.56 B146.53 B138.81 B134.71 B135.16 B133.96 B Dette totale —————— Dette nette ——————

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'.

ABBV

Financials

AbbVie Inc. Common Stock

Nouvelles

AbbVie Inc. (ABBV) Presents at EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities Transcript

AbbVie (ABBV) Up 3.5% Since Last Earnings Report: Can It Continue?

Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR)

AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?

AbbVie obtient l’approbation de l’UE pour une extension de l’indication de Venclyxto dans la LLC

IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

Building A $100,000 All-Weather Dividend Portfolio For May 2026 (NYSEARCA:SPY)

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?

AbbVie obtient l’approbation de la FDA pour un traitement contre le BPDCN

How Did AbbVie's Oncology Portfolio Perform in Q1 Despite Headwinds?

Dividend Income Update Q1 2026